AIM

#4751
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.39
0.39
Faixa anual
0.21
20.35
Mudança diária
-7.14%
Mudança mensal
-23.54%
Mudança em 6 meses
-75.65%
Mudança anual
-95.41%
Fechamento anterior
0.4 2
Open
0.3 9
Mínimo
0.3 9
High
0.3 9
Volume
233
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Notícias